Friday, May 17, 2013

• Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual MeetingPR Newswire( (Fri, May 17)

Thursday, May 9, 2013

• Shire Wins Patent Trial Against Watson Concerning LIALDA®PR Newswire( (Thu, May 9)

Thursday, May 2, 2013

• New Chief Executive Reports Q1 Results and Sets out Strategy for GrowthPR Newswire( (Thu, May 2)

Wednesday, May 1, 2013

• Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHDPR Newswire( (Wed, May 1)

Thursday, April 25, 2013

• Shire Settles All Pending Litigation with Actavis and Watson Concerning INTUNIV®PR Newswire( (Thu, Apr 25)

Wednesday, April 24, 2013

• BRAVE Awards Now Accepting NominationsPR Newswire( (Wed, Apr 24)

Tuesday, April 9, 2013

• Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare DiseasesPR Newswire( (Tue, Apr 9)

Monday, March 25, 2013

• Shire to Acquire SARcode Bioscience, Expands Presence in OphthalmologyPR Newswire( (Mon, Mar 25)

Tuesday, March 12, 2013

• Shire Acquires Premacure ABPR Newswire( (Tue, Mar 12)

Thursday, February 28, 2013

• Shire Supports Rare Disease Day 2013PR Newswire( (Thu, Feb 28)

Tuesday, February 19, 2013

• Shire's VPRIV® Wins First Ever "Novel Treatment Award" From Lysosomal Disease Network at Their 9th WORLD SymposiumPR Newswire( (Tue, Feb 19)

Thursday, February 14, 2013

• Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013PR Newswire( (Thu, Feb 14)

Wednesday, February 13, 2013

• Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its ComplicationsPR Newswire( (Wed, Feb 13)